PAGANI, RACHELE
PAGANI, RACHELE
HER2-targeted therapies for salivary gland cancers
2024 Filippini D.M.; Pagani R.; Tober N.; Lorini L.; Riefolo M.; Molinari G.; Burato A.; Alfieri S.; Bossi P.; Presutti L.
Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond
2023 Mosca M.; Nigro M.C.; Pagani R.; De Giglio A.; Di Federico A.
Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: A single-institution experience
2022 Comito F.; Aprile M.; Pagani R.; Siepe G.; Sperandi F.; Gruppioni E.; Altimari A.; De Biase D.; Melotti B.
Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma
2022 Comito, Francesca; Pagani, Rachele; Grilli, Giada; Sperandi, Francesca; Ardizzoni, Andrea; Melotti, Barbara
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes
2022 Di Federico A.; Mosca M.; Pagani R.; Carloni R.; Frega G.; De Giglio A.; Rizzo A.; Ricci D.; Tavolari S.; Di Marco M.; Palloni A.; Brandi G.
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumour Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes
2022 Alessandro Di Federico, Mirta Mosca, Rachele Pagani, Riccardo Carloni, Giorgio Frega, Andrea De Giglio, Alessandro Rizzo, Dalia Ricci, Simona Tavolari, Mariacristina Di Marco, Andrea Palloni, Giovanni Brandi.
Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges
2020 Rizzo A.; Federico A.D.; Ricci A.D.; Frega G.; Palloni A.; Pagani R.; Tavolari S.; Marco M.D.; Brandi G.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| HER2-targeted therapies for salivary gland cancers | Filippini D.M.; Pagani R.; Tober N.; Lorini L.; Riefolo M.; Molinari G.; Burato A.; Alfieri S.; B...ossi P.; Presutti L. | 2024-01-01 | ORAL ONCOLOGY | - | 1.01 Articolo in rivista | Filippini_2024.pdf |
| Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond | Mosca M.; Nigro M.C.; Pagani R.; De Giglio A.; Di Federico A. | 2023-01-01 | BIOMOLECULES | - | 1.01 Articolo in rivista | biomolecules-13-01803.pdf |
| Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: A single-institution experience | Comito F.; Aprile M.; Pagani R.; Siepe G.; Sperandi F.; Gruppioni E.; Altimari A.; De Biase D.; M...elotti B. | 2022-01-01 | MELANOMA RESEARCH | - | 1.01 Articolo in rivista | - |
| Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma | Comito, Francesca; Pagani, Rachele; Grilli, Giada; Sperandi, Francesca; Ardizzoni, Andrea; Melott...i, Barbara | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-00271-v2.pdf |
| Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes | Di Federico A.; Mosca M.; Pagani R.; Carloni R.; Frega G.; De Giglio A.; Rizzo A.; Ricci D.; Tavo...lari S.; Di Marco M.; Palloni A.; Brandi G. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | articolo 2022 Immunotherapy in Pancreatic Cancer Why Do We Keep Failing A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes.pdf |
| Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumour Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes | Alessandro Di Federico, Mirta Mosca, Rachele Pagani, Riccardo Carloni, Giorgio Frega, Andrea De G...iglio, Alessandro Rizzo, Dalia Ricci, Simona Tavolari, Mariacristina Di Marco, Andrea Palloni, Giovanni Brandi. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-02429 (1).pdf |
| Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges | Rizzo A.; Federico A.D.; Ricci A.D.; Frega G.; Palloni A.; Pagani R.; Tavolari S.; Marco M.D.; Br...andi G. | 2020-01-01 | CANCER CONTROL | - | 1.01 Articolo in rivista | Targeting BRAF-Mutant Biliary.pdf |